Dizal Announces Positive Pooled Data of Sunvozertinib in EGFR Tyrosine Kinase Inhibitor-Resistant Non-Small Cell Lung Cancer Published in Lung Cancer ...Middle East

Sunvozertinib, as a single agent, demonstrated promising antitumor activity and favorable safety profile in heavily pretreated patients with EGFR-mutated NSCLC who had developed resistance to EGFR TKI treatment SHANGHAI, Dec. 11, 2024 /PRNewswire/ -- Dizal (SSE:688192), a...

Hence then, the article about dizal announces positive pooled data of sunvozertinib in egfr tyrosine kinase inhibitor resistant non small cell lung cancer published in lung cancer was published today ( Wednesday 11/12/2024 - 01:12 PM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Dizal Announces Positive Pooled Data of Sunvozertinib in EGFR Tyrosine Kinase Inhibitor-Resistant Non-Small Cell Lung Cancer Published in Lung Cancer )

Also on site :

• Ukraine has violated Victory Day ceasefire – Moscow
• Google’s plan to win the AI health race? Play nice with Apple and other rivals
• The 1981 Wedding That Drew Over 30 Million Viewers Ranked No. 1 Greatest Soap Moment Ever